Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs Navio MD

By GLP-1 ScorecardUpdated

Fierce Health
Site position #398

Lower grade

Navio MD
Site position #127

Higher grade

Score comparison

Navio MD has the higher recorded score — 69.8/100 to 59/100.

Navio MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNavio MD +24
33
57
Dose & formulationEven
77
77
Clinical oversightNavio MD +13
74
87
Labs & monitoringNavio MD +2
52
54
FulfillmentNavio MD +10
75
85
Contract termsNavio MD +8
47
55
Fierce Health · top barNavio MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFierce HealthNavio MD
WeighScore59/10069.8/100
GradeCC
Site position#398#127
Semaglutide$297/mo (3-month plan, compounded)$345/mo (starting dose, brand-name)
Tirzepatide$497/mo (3-month plan, compounded)$189/mo (starting dose, compounded)
Coverage30 states48 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Fierce Health

Site position #398 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

What to consider

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
Navio MD

Site position #127 · C

Strengths

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

What to consider

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard